[PDF] Top 20 Soft Tissue Sarcomas and p53 Mutations

... (1997) Da- tabase of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Roessner A, Schneider-Stock R, Radig K, Neu-[r] ... See full document

... Background: Soft tissue sarcomas (STSs) are a heterogeneous group of malignant tumors that can be divided into specific reciprocal translocation associated in STSs (SRTSs) and nonspecific reciprocal ... See full document

... harboring p53 muta- tions, likely through a clonal expansion mechanism ...oncogenic mutations to expand into a tumor unencumbered by cell competition from the bone ...injury-induced sarcomas (35), ... See full document

... proliferation. Mutations generally occur in the DNA encoding the intracellular part exon 11, but can also occur in exons 9 and rarely 13 and ...1. Mutations in c-kit and PDGFRA are mutually ...described ... See full document

... activating mutations in gastrointestinal stromal tumors (GISTs) that transformed this chemo-insensitive, routinely fatal disease to one of the most treatable sarcomas, there has been little progress in ... See full document

... and arresting cell cycle at the G2/M phases in STS, in particular dedifferentiated liposarcomas, while we did not observed a synergistic effect in leiomyosarcomas. One possible explanation is that our LMS cell lines were ... See full document

... the tissue lineage commitment of precursor cells. Mutations of molecular components of Notch signaling have been involved in different genetic disorders ...is, soft tissue sarcomas ... See full document

... 7. Cohen N, Sharma M, Kentsis A, Perez JM, Strudwick S, Borden KL: PML RING suppresses oncogenic transformation by reduc- ing the affinity of eIF4E for mRNA. EMBO J 2001, 20:4547-4559. 8. Pearson M, Carbone R, Sebastiani ... See full document

... Notes: Liposarcomas consist of four subtypes: well-differentiated liposarcoma (WDLS), dedifferentiated liposarcoma, myxoid liposarcoma (MLS), and pleomorphic liposarcoma (PLS). A common characteristic of WDLS, DDLS, and ... See full document

... Time-dose and concentration dependency of MLN-8237 to inhibit Aurora A and B was tested in LS141 by choosing a range of concentrations from 10 nM to 10 µM from 12 to 48 hours of exposure. We elected to monitor phospho ... See full document

... Soft tissue sarcomas (STS) are a rare group of tumors of mesenchymal origin comprising about 1% of all malig- nancies in the ...(EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) 62012 ... See full document

... Our results support the notion that preoperative radi- otherapy is a successful strategy in cases of high-risk tumours, such as large-volume ones and those in close proximity to the neurovascular bundle. In our cohort, ... See full document

... A multicenter, randomized, controlled, open-label study was conducted in Japan on 73 pretreated TRS patients including 19% synovial sarcoma, 8% mesenchymal chond- rosarcoma, and 8% extraskeletal Ewing’s sarcoma/primitive ... See full document

... 21 Sarcomas requiring resection of femoral diaphyseal bone but sparing the hip and knee joints can be reconstructed with a variety of allograft and metal component options with high functional ...deep ... See full document

... Soft-tissue sarcoma (STS) is a rare form of cancer that develops in connective tissues. Approximately 3,300 new cases are diagnosed every year in the UK and the 5-years survival rate is ∼ 53% (1). STS ... See full document

... alveolar soft part sarcoma; AYAs, adolescent and young adults; CAR, chimeric antigen receptor; COG, Children’s Oncology Group; CR, complete remission; DSRCT, desmoplastic small round cell tumor; EGFR, endothelial ... See full document

... extremity sarcomas, however, there is still some limit of limb-salvage for such as huge pelvic tumors considering frequent postoperative infection and postoperative limb function, thus for such ... See full document

... Abstract: Malignant fibrous histiocytoma (MFH) is the most common soft-tissue sarcoma in late adult life. Unfortunately, advanced MFH has a poor prognosis due to a lack of effective drugs. We present here a ... See full document

... of soft-tissue sarcomas and is the mainstay of treatment in patients with advanced or metastatic ...in soft-tissue sarcomas is less well ...localised soft-tissue ... See full document

... a soft tissue sarcoma can certainly influence the technical ease with which resectability can be accomplished, hence it affects the potential for local ...thigh sarcomas disease-free and overall ... See full document